Feb 21, 2023 / 02:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the preliminary results of the BeAT-HF post-market randomized clinical trial conference call. (Operator Instructions)
I would now like to hand the conference over to your first speaker for today, Nadim Yared. You may begin.
Nadim Yared - CVRx, Inc. - CEO, President & Director
Thank you and good morning. Thank you, everyone, for joining us today for this important update. I am excited to share with you some additional context to the press release that we issued earlier this morning, where we shared the preliminary top line results of the post-market phase of our BeAT-HF trial. As we stated in the press release, we have secured a spot at the Transcatheter Heart Failure Therapy Conference or THT in short, in Boston on March 21 at 10:45 a.m. Eastern Time for a member of the Executive Steering Committee of the trial to present the full data and we will hold an investors conference call later that day. But for now, I will be limited to speaking only about the preliminary results that we shared in our
CVRx Inc To Discuss The Preliminary Results Of The BeAT-HF Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers